Previous close | 0.1000 |
Open | 0.5000 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 105.00 |
Expiry date | 2024-05-17 |
Day's range | 0.0500 - 0.5000 |
Contract range | N/A |
Volume | |
Open interest | 220 |
NEW YORK, May 07, 2024--Turnspire Capital Partners LLC ("Turnspire") announced today that an affiliate has signed a definitive agreement to acquire the nutraceuticals business of Ashland Inc. (NYSE: ASH) ("Ashland Nutraceuticals" or the "Business").
WILMINGTON, Del., May 07, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) announced today that it has signed a definitive agreement to sell its nutraceuticals business to Turnspire Capital Partners LLC (“Turnspire”). The transaction is expected to close in the calendar third quarter 2024, subject to the satisfaction of customary closing conditions. Ashland's nutraceuticals business supplies a broad portfolio of active ingredients and formulation aids to nutritional product companies, as well a
Here is how Ashland (ASH) and Buenaventura (BVN) have performed compared to their sector so far this year.